Phase III PEG-Intron in HIV-infected Patients (Study P00738)

Clinical trial NCT00035360 · COMPLETED

Trial details

NCT number: NCT00035360
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV Infections AIDS

Start date: 2002-03-01
Primary completion: 2003-10-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.